Safety, tolerability, pharmacokinetics and pharmacodynamics of ARV-102 in healthy participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507910-28-00

Acronym

ARV-102-101

Enrollment

Registered

2023-12-21

Start date

2024-01-04

Completion date

2025-02-13

Last updated

2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026